A 29-year-old man undergoes a total proctocolectomy with end-to-end ileostomy after 2 years of surveillance for ulcerative colitis.

Background: This case presents a 56-year-old male with obstructive jaundice, complicated by bile duct stones, bile duct dilation, and a possible biliary-enteric fistula. This case contributes to the ...

In pregnant women with mild biliary AP, cholecystectomy performed during the second or third trimester is safe and effective, ...

In a randomized trial, 1 day of octreotide infusion combined with endoscopic therapy proved noninferior to 5 days for acute ...

Given the unmet need of fatigue in primary biliary cholangitis (PBC), the PBC working group of the European Reference Network for Rare Liver Diseases assessed and summarised the current evidence ...

The proportion of male PBC patients in Japan nearly doubled from 12.4% to 20.6% between 2010 and 2021, while the mean age at diagnosis increased by approximately 5 years, suggesting PBC should no ...

• Cholangiocarcinomas (CCAs) are a heterogeneous group of bile duct cancers currently classified as intrahepatic (iCCA), perihilar (pCCA) and distal (dCCA) • The most frequent macroscopic ...

Your doctor uses a long flexible tube with a small camera and light at the end, called an endoscope. It's also sometimes called a duodenoscope. They pass this tube through your mouth, throat, stomach ...

Primary sclerosing cholangitis is a chronic liver disease caused by progressive inflammation and scarring of the bile ducts of the liver. The inflammation impedes the flow of bile to the duodenum, ...

Ipsen has been given accelerated approval by the FDA for Iqirvo, which becomes the first dual PPAR alpha/delta agonist for rare cholestatic liver disease primary biliary cholangitis (PBC). Iqirvo ...

Advanz Pharma's bid to keep its Ocaliva treatment for rare liver disease primary biliary cholangitis (PBC) on the EU market has ended in failure. The European Commission revoked the conditional ...